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ABSTRACT	Gabriella	Noel	Gallo:	Prenatal	Arsenic	Exposure	is	Associated	with	Decreased	Mitochondrial	DNA	Copy	Number	and	Increased	Genomic	Indicators	of	Reactive	Oxygen	Species	in	Newborn	Cord	Blood	Leukocytes	(Under	the	direction	of	Rebecca	C.	Fry)		 To	better	understand	the	mechanisms	of	inorganic	arsenic	(iAs)	toxicity	during	the	prenatal	 period,	 mitochondrial	 DNA	 (mtDNA)	 copy	 number	 was	 examined	 in	 the	Biomarkers	of	Exposure	to	ARsenic	(BEAR)	pregnancy	cohort	from	Gómez	Palacio,	Mexico.	Newborn	 cord	 blood	 and	 maternal	 whole	 blood	 leukocytes	 examined	 for	 mtDNA	 copy	number	 were	 compared	 to	 iAs	 in	 maternal	 drinking	 water	 and	 total	 maternal	 urinary	arsenic	 (U-tAs).	 Analysis	 of	 mtDNA	 and	 iAs	 exposure	 measures	 revealed	 a	 negative	association	between	maternal	U-tAs	 and	newborn	mtDNA	content.	Additional	 analysis	 of	gene	expression	changes	associated	with	mtDNA	copy	number	identified	3	genes	that	are	known	to	play	a	role	in	ROS	protection,	and	22	genes	that	have	been	shown	to	be	altered	by	arsenic	 exposure.	 This	 study	 highlights	mtDNA	 as	 a	 novel	 responder	 to	 prenatal	 arsenic	exposure	that	may	contribute	to	mechanisms	of	iAs	toxicity	in	utero.		
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CHAPTER	1.	INTRODUCTION	Arsenic	exposure	through	drinking	groundwater	water	is	a	major	public	health	problem,	and	it	is	estimated	to	effect	more	than	100	million	people	globally	(Uddin	&	Huda,	2011).	Elevated	levels	of	arsenic	exposure	are	linked	to	adverse	health	outcomes	(Vahter,	2009).	As	a	known	carcinogen,	inorganic	arsenic	targets	the	lung,	skin,	liver,	prostate	and	urinary	bladder,	among	other	sites	(NTP,	2011).	Inorganic	arsenic	exposure	is	also	linked	to	numerous	non-cancerous	health	outcomes	such	as	heart	disease,	diabetes,	liver	hypertrophy,	and	detrimental	effects	on	intellectual	function	and	memory	(Kapaj,	Peterson,	Liber,	&	Bhattacharya,	2006).	The	World	Health	Organization	(WHO)	recommends	a	limit	of	10	µg/L	of	arsenic	in	drinking	water	(WHO,	2006).	However,	levels	of	arsenic	far	beyond	this	limit	have	been	found	in	drinking	sources	around	the	globe,	including	India,	Bangladesh,	Vietnam,	Mexico,	and	the	United	States	(ATSDR,	2007).		In	addition	to	health	effects	associated	with	chronic	exposure,	exposures	that	occur	during	pregnancy	are	also	of	concern.	Pregnant	women	and	their	fetuses	are	especially	susceptible	to	inorganic	arsenic	exposure	and	the	associated	adverse	health	effects	(Vahter,	2009).	Inorganic	arsenic	is	a	developmental	toxicant	that	can	reach	fetal	organs	by	easily	crossing	the	placenta	(Concha	et	al.,	1998).	Exposure	during	pregnancy	has	been	associated	with	both	early	life	and	later	life	diseases.	For	example,	prenatal	inorganic	arsenic	exposure	has	been	associated	with	increased	risk	of	spontaneous	abortion,	low	birth	weight,	decreased	head	and	chest	circumference	(Rahman	et	al.,	2009),	infant	mortality,	and	increased	risk	of	infection	in	infants	(Rahman,	Vahter,	Ekström,	&	Persson,	2010).	In	
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addition	to	adverse	early	life	outcomes,	prenatal	exposure	to	arsenic	is	associated	with	increased	later	in	life	disease	(Dauphiné	et	al.,	2011;	Naujokas	et	al.,	2013;	Smith	et	al.,	2012;	Yuan	et	al.,	2010)	as	well	as	higher	mortality	rates	in	adulthood	(Smith	et	al.,	2012).	A	potential	mechanism	that	may	link	pre-natal	arsenic	exposure	to	disease	outcomes	is	through	effects	to	mitochondrial	DNA	(mtDNA).	As	an	intracellular	organelle,	mitochondria	provide	the	cell	with	energy	through	the	production	of	adenosine-5’-triphosphate	(ATP)	by	oxidative	phosphorylation	(Janssen	et	al.,	2015),	and	are	critical	in	maintaining	proper	organ	and	cell	function	(Shaughnessy	et	al.,	2015).	Both	the	nuclear	and	mitochondrial	genome	are	essential	contributors	to	this	cellular	energy-producing	apparatus,	and	of	the	more	than	80	proteins	involved	in	human	oxidative	phosphorylation,	13	are	encoded	by	maternally	inherited	mtDNA	(Xin	&	Butow,	2005).		Multiple	copies	of	double	stranded	circular	mtDNA	are	contained	in	the	mitochondria,	and	these	copies	can	change	in	number	in	response	to	damage	or	mutations	(Janssen	et	al.,	2012).	Variation	in	mtDNA	content	is	a	proven	marker	of	mitochondrial	damage	(Hou	et	al.,	2010),	and	has	a	high	rate	of	mutation	(Linnane,	Ozawa,	Marzuki,	&	Tanaka,	1989).	Changes	in	mtDNA	content	is	an	important	area	of	study	as	it	influences	mitochondrial	function,	which	has	been	linked	to	a	variety	of	disease	mechanisms	(Hou	et	al.,	2010).		There	is	evidence	that	exposure	to	environmental	contaminants	is	associated	with	both	oxidative	stress	and	mtDNA	damage.	For	example,	various	environmental	oxidative	stressors	exist	such	as	environmental	pollutants,	smoke,	xenobiotics,	or	temperature	(Baccarelli,	2015),	and	these	stressors	can	influence	mitochondrial	function.	mtDNA	is	incredibly	vulnerable	to	reactive	oxygen	species	(ROS)	induced	damage	(Linnane	et	al.,	1989),	and	its	content	has	been	shown	to	respond	to	environmental	exposures	that	induce	
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oxidative	stress	(Janssen	et	al.,	2015).	Environmental	toxicants	such	as	Cadmium	(Cd),	Dibenzofuran	(DBF),	Bisphenol	A	(BPA),	and	ambient	particulate	matter	(PM)	have	been	associated	with	mitochondrial	malfunction	or	changes	in	mtDNA	copy	number	(Byun	et	al.,	2013;	Duarte	et	al.,	2013;	Kurochkin,	Etzkorn,	Buchwalter,	Leamy,	&	Sokolova,	2011;	Lin	et	al.,	2013).	The	effects	of	these	environmental	toxicants	are	profound	in	the	mitochondria,	since	mitochondria	accumulate	DNA	damage	at	a	five-fold	rate	as	compared	to	nuclear	DNA	(Baccarelli,	2015).	The	effects	of	arsenic	on	mtDNA	are	currently	unknown.		In	the	present	study,	we	set	out	to	examine	the	relationship	between	prenatal	arsenic	exposure	in	a	human	population	in	Gómez	Palacio,	Mexico	and	mtDNA	in	DNA	derived	from	both	maternal	whole	blood	and	fetal	cord	blood	leukocytes.	We	hypothesized	that	prenatal	arsenic	exposure	would	be	associated	with	a	changes	in	mtDNA	copy	number	and	an	increase	in	the	expression	of	genes	that	are	indicators	of	ROS	and	arsenic	exposure.	
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CHAPTER	2.	METHODS	
Study	Subjects	and	Subcohort	Selection	From	August	2011	through	March	2012,	pregnant	adult	women	were	recruited	before	delivery	at	the	General	Hospital	of	Gómez	Palacio	as	BEAR	participants.	The	requirements	for	participation	for	each	woman	included	a	minimum	residence	of	1	year	in	the	Gómez	Palacio	region,	confirmation	of	a	pregnancy	without	complications,	and	good	overall	health	status.	At	the	start,	221	women	were	approached	for	the	study.	Of	those,	93%	(n	=	206)	provided	informed	consent	for	participation	in	the	study.	Six	women	were	not	included	in	the	study	as	a	result	of	confirmation	of	a	twin	pregnancy	(n	=	1;	0.5%)	or	sample	collection	failure	(n	=	5;	2.4%).	Of	this	number,	a	total	of	164	women	were	included	in	our	study’s	subcohort,	as	data	on	their	mtDNA	was	available.	The	mean	gestational	age	at	birth	was	39.4	weeks	(range,	36–42	weeks).	All	procedures	associated	with	this	study	were	approved	by	the	institutional	review	boards	of	Universidad	Juarez	del	Estado	de	Durango	(UJED),	Gómez	Palacio,	Durango,	Mexico,	and	the	University	of	North	Carolina	at	Chapel	Hill	(UNC-Chapel	Hill)	(Laine	et	al.,	2015).		Questionnaires,	administered	by	a	social	worker,	gathered	information	surrounding	the	women’s	age,	education,	occupation,	time	living	at	residence,	smoking	status	and	alcoholic	beverage	consumption	during	pregnancy,	daily	prenatal	supplement	intake,	residence	location,	seafood	consumption,	source	and	daily	consumption	of	drinking	and	cooking	water,	and	source	of	bathing	water.	In	addition,	information	on	previous	pregnancy	outcomes	including	number	of	pregnancies	and	number	of	previous	pregnancy	
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losses	was	gathered.	Physicians	gathered	information	on	birth	outcomes	and	measures	of	the	children,	including	newborn	birth	weight,	newborn	length,	gestational	age,	head	circumference,	placental	weight,	and	5-min	Appearance,	Pulse,	Grimace,	Activity,	Respiration	(APGAR)	score	at	time	of	delivery	by	the	physician	(Montgomery	2000).	Data	including	preterm	birth	(gestational	age	<	37	weeks),	low	birth	weight	(LBW;	<	2,500	g),	small	for	gestational	age	(SGA;	birth	weight	<	10th	percentile),	and	large	for	gestational	age	(LGA;	birth	weight	>	90th	percentile)	were	collected	to	determine	adverse	outcomes	(Laine	et	al.,	2015).		SGA	and	LGA	categories	were	based	on	newborn	data	collected	from	northern	regions	of	Mexico	(Montes-Núñez	et	al.,	2011;	Ríos,	Tufiño-Olivares,	Reza-López,	Sanín,	&	Levario-Carrillo,	2008).	
Sample	Collection	Before	birth,	maternal	spot	urine	samples	were	collected	at	the	hospital.	These	samples	were	immediately	transferred	to	cryovials,	and	placed	in	liquid	nitrogen.	Aliquots	of	urine	samples	were	shipped	on	dry	ice	to	UNC-Chapel	Hill	and	immediately	stored	at	–80°C.	The	research	team	collected	a	drinking-water	sample	at	the	homes	of	each	of	the	study	participants	within	4	weeks	of	newborn	delivery.	The	subjects’	primary	drinking-water	source	determined	the	drinking-water	samples	that	were	collected.	The	women	were	informed	of	the	levels	of	iAs	in	their	drinking	water	within	3	months	of	delivery,	as	the	levels	were	not	available	before	the	birth	of	their	children	(Laine	et	al.,	2015).	
Detection	of	Arsenic	in	Drinking	Water	and	Urine	UJED,	Mexico	measured	the	concentrations	of	iAs	in	drinking	water	(micrograms	As/L;	DW-iAs)	using	hydride	generation–atomic	absorption	spectrometry	(HG-AAS)	supported	by	a	FIAS-100	flow	injection	accessory	system	as	described	previously	(Devesa	
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et	al.,	2004;	Le	&	Ma,	1998).	The	HG-AAG	limit	of	detection	(LOD)	for	iAs	in	drinking	water	by	was	0.46	µg	As/L.	The	Trace	Elements	in	Water	standard	reference	material	(SRM	1643e)	(National	Institute	of	Standards	and	Technology,	Gaithersburg,	MD)	was	used	for	quality	control.	UNC-Chapel	Hill	conducted	all	urine	analyses.	HG-AAS	determined	the	concentrations	of	urinary	arsenicals,	including	inorganic	arsenic	(U-iAs),	monomethylated	arsenic	(U-MMAs),	and	dimethylated	arsenic	(U-DMAs)	with	cryotrapping	(Devesa	et	al.	2004;	Hernández-Zavala	et	al.	2008,	2009).	Pentavalent	iAs	standards	(>	98%	pure)	were	used	to	prepare	five-point	calibration	curves	as	described	previously	(Hernández-Zavala	et	al.	2008),	and	the	SRM	2669	Arsenic	Species	in	Frozen	Human	Urine	(National	Institute	of	Standards	and	Technology)	was	used	for	quality	control	(Del	Razo	et	al.,	2011).	U-iAs,	U-MMAs,	and	DMAs	had	LOD’s	of	0.2,	0.1,	and	0.1	µg	As/L,	respectively.	A	handheld	refractometer	(Reichert	TX	400	#13740000;	Reichert	Inc.,	Depew,	NY)	was	used	to	measure	the	specific	gravity	(SG)	of	each	urine	sample.	The	concentrations	of	U-iAs,	in	each	urine	sample	were	adjusted	using	the	following	equation:	iAs	×	(mean	SG	–	1)/(individual	SG	–	1)	in	order	to	account	for	differences	in	water	intake/differential	hydration	as	previously	described	(Nermell	et	al.	2008;	Yassine	et	al.	2012).	Urinary	concentrations	of	total	arsenic	(U-tAs)	is	the	sum	of	iAs,	MMAs,	DMAs,	and	were	reported	as	SG-adjusted	values	(micrograms	As/L	urine)	(Laine	et	al.,	2015).	
DNA	Isolation	and	Genotyping	DNA	was	isolated	from	the	200	maternal	whole	blood	and	200	fetal	cord	blood	samples	using	the	QIAamp	DNA	Blood	Mini	Kit	(QIAGEN,	Valencia,	CA)	according	to	the	manufacturer’s	protocol	and	stored	at	−80◦C.	Quality	and	concentration	of	DNA	was	
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evaluated	on	a	NanoDrop	2000c	UV–vis	spectrophotometer	(Thermo	Scientific)	(Drobná	et	al.,	2016).	Of	these,	162	maternal	and	140	fetal	samples	were	available	for	mtDNA	analysis.	An	assay	based	on	real-time	quantitative	polymerase	chain	reaction	(RT-PCR)	was	used	for	both	nuclear	DNA	(nDNA)	and	mtDNA	quantification	using	TaqMan	probe	as	a	fluorescent	dye.	We	amplified	the	region	of	the	mtDNA	using	the	TaqMan	probe	corresponding	to	forward	primer	5’	CCACGGGAAACAGCAGTGATT	3’	(Integrated	DNA	Technologies)	and	reverse	primer	5’	CTATTGACTTGGGTTAATCGTGTGA	3’	(Integrated	DNA	Technologies).	We	amplified	the	region	of	the	nucleic	DNA	(nDNA)	using	the	TaqMan	probe	corresponding	to	5’	TGCCAGCCACCGCG	3’-MGB	(ThermoFisher,	#4316034).	The	real-time	PCR	conditions	consisted	of	initial	denaturation	at	50	°C	for	2	minutes	and	Taq	polymerase	activation	at	95	°C	for	10	minutes,	followed	by	40	cycles	at	95	°C	for	15	seconds	and	60	°C	for	1	minute,	with	a	melting	curve	analysis	of	65	°C	for	1	minute.	Real-time	quantitative	PCR	was	carried	out	using	Stratagene	nX3005P	qPCR	System	(Agilent	Technologies).	The	ratio	of	the	mitochondrial	gene	(mtDNA	12S	ribosomal	ribonucleic	acid)	to	a	nuclear	gene	(Ribonuckease	P	gene),	which	is	normalized	to	the	reference	DNA	sample	(a	pool	of	200	test	samples)	to	obtain	relative	mitochondrial	DNA	copy	number	values	controlled	for	plate	effects.		To	determine	the	quantities	of	mtDNA	and	nDNA	present	in	samples,	the	average	threshold	cycle	number	(Ct)	values	of	the	nDNA	and	mtDNA	were	obtained	from	each	case.	The	level	of	mtDNA	was	calculated	using	the	delta	Ct	(ΔCt)	of	average	Ct	of	mtDNA	and	nDNA	(ΔCt=CtmtDNA-CtnDNA)	in	the	same	well	as	an	exponent	of	2	(2-ΔCt)	(Mondal	et	al.,	2013).	
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Statistical	Analysis	Data	were	analyzed	using	SAS	9.3	(SAS	Institute	Inc.,	Cary,	NC).	Firstly,	simple	regression	analyses	were	conducted	to	determine	the	relationship	between	mtDNA	copy	number	in	mothers	and	infant	cord	samples,	as	it	is	not	known	if	they	are	related.	These	were	controlled	for	maternal	age	at	delivery	(as	a	continuous	variable),	education	level	as	a	measure	of	socioeconomic	status	(below	high	school,	high	school	and	above),	smoking	status	(dichotomized	as	yes/no),	and	alcoholic	beverage	consumption	during	pregnancy	dichotomized	as	yes/no).	Secondly,	we	analyzed	the	relationship	between	the	arsenic	measures:	drinking	water	arsenic,	maternal	urinary	arsenic,	and	infant	cord	plasma	arsenic.	Lastly,	mtDNA	copy	number	in	infants	was	merged	into	existing	genome-wide	gene	expression	data	(Rager	et	al.,	2014).	Of	the	38	individuals	for	which	genome-wide	gene	expression	analysis	was	conducted,	there	were	20	that	were	analyzed	for	mtDNA	copy	number.	These	subjects	were	used	to	interrogate	the	relationship	between	mtDNA	copy	number	and	altered	gene	expression	through	linear	regression	analysis	where	mtDNA	was	the	independent	variable	and	gene	expression	was	the	dependent	variable.			 To	understand	the	relevance	of	mtDNA-associated	genes,	a	formal	enrichment	analysis	was	carried	out	using	Ingenuity	Network	Analysis	(IPA)	followed	by	a	gene	set	enrichment	analysis	(GSEA)	analysis.	The	affymetrix	chip	was	selected	as	the	background	for	the	enrichment	analyses.	Predicted	network	enriches	among	this	gene	set	were	analyzed	and	reported	and	canonical	pathways	within	the	constructed	networks	were	then	identified.	IPA	(Ingenuity	Systems,	Redwood	City,	CA)	networks	were	algorithmically	constructed	based	on	connectivity.	Significance	was	assessed	using	the	righttailed	Fisher’s	exact	test.	Pathways	with	enrichment	p-values	<	0.05	were	considered	significantly	
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enriched	with	the	predicted	targets.	GSEA	(PMID:	16199516Subramanian,	Tamayo,	et	al.	(2005,	PNAS	102,	25545-15550))	was	used	as	a	second	method	to	examine	pathway	enrichment.	GSEA	uses	a	rank-based	analysis	method	to	assess	biological	enrichment,	and	examines	discordant	differences	between	two	biological	states	by	calculating	an	enrichment	score	within	a	ranked	list.	Secondly,	we	assessed	which	of	these	genes	had	been	previously	associated	with	arsenic	exposure	and	reactive	oxygen	species	generation	as	mtDNA	is	thought	to	play	a	role	in	ROS	formation	(Andreu	et	al.	2009).		This	allowed	for	identification	of	important	genes	already	known	to	be	associated	with	potential	biological	pathways	previously	identified	(Laine	&	Fry,	2016).		
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CHAPTER	3.	RESULTS	
Demographics,	Birth	Outcomes,	and	Leukocyte	mtDNA	Content	of	Mothers	and	
Newborns	in	the	Study	Population	The	details	of	this	study	population	have	been	described	briefly	(Laine	et	al.,	2015;	Rager	et	al.,	2014).	In	this	cohort,	the	age	of	the	women	ranged	from	18	to	40	years	old.	The	majority	of	the	women	had	a	high	school	education	or	above,	were	non-smokers,	and	did	not	consume	alcohol.	There	were	73	male	and	67	female	newborns	in	this	cohort.	Their	weights	at	birth	ranged	from	2100	g	to	4690	g,	and	their	gestational	ages	ranged	from	36	to	42	weeks.	The	mtDNA	copy	number	of	the	mothers’	whole	blood	leukocytes	ranged	from	27.1-3294.5	and	the	mtDNA	copy	number	of	the	newborns	ranged	from	11.6-5431.6	(Table	1).	 	
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Table	1.	Selected	demographic	characteristics,	levels	of	iAs	in	drinking	water	and	urinary	arsenicals,	and	mtDNA	content	of	the	present	BEAR	study.	Characteristic		 Mean	[range	or	%]	Maternal	age	at	delivery	(years)	 24.1	[18-40]	Education							Below	High	School						High	School	and	Above	 	42	[25.6]	122	[74.4]	Smoking	Status						Yes						No	 	11	[6.7]	153	[93.3]	Alcohol	Consumption							Yes						No	 	36	[22.0]	128	[78.0]	Newborn	Sex						Male						Female	 	73	[52.14]	67	[47.86]	Birth	Weight	(g)	 3316	[2100-4690]	Gestational	Age	(weeks)	 39.4	[36.0-42.0]	Drinking	Water	Arsenic	(µg/L)						Maternal							Newborn	 	25.5	[<LOD-235.6]	22.7	[<LOD-226]	Maternal	Urinary	Arsenic	(µg/L)						Maternal							Newborn	 	38.3	[<LOD-319.7]	36.0	[<LOD-261.4]	Infant	Plasma	Arsenic	(ng/L)	 336.4[<LOD-2261.6]	mtDNA	content							Maternal							Newborn		 	298.8	[27.1-3294.5]	295.8	[11.6-5431.6]	
Maternal	Whole	Blood	Leukocyte	mtDNA	Content	is	Not	Associated	with	Newborn	
Cord	Blood	Leukocyte	mtDNA	Content.		We	set	out	to	examine	whether	the	mtDNA	copy	number	in	maternal	whole	blood	leukocyte	DNA	and	newborn	cord	blood	leukocyte	DNA	was	similar.	Interestingly,	the	mtDNA	copy	number	was	not	associated	(p-value=	0.1995),	suggesting	differences	in	mtDNA	copy	number	between	mother	and	infant.		
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Figure	1.	Newborn	cord	blood	leukocyte	mtDNA	copy	number	versus	maternal	whole	blood	leukocyte	mtDNA	copy	number.	Log-transformed	newborn	cord	blood	leukocyte	mtDNA	copy	numbers	are	plotted	against	log-transformed	maternal	whole	blood	leukocyte	mtDNA	copy	number.		
Maternal	Total	Urinary	Arsenic	is	associated	with	Newborn	Cord	Blood	Leukocyte	
mtDNA	Content.		We	next	set	out	to	determine	whether	arsenic	exposure	was	associated	with	mtDNA	copy	number	in	either	maternal	leukocyte	DNA	or	newborn	leukocyte	DNA.	We	compared	all	measures	of	arsenic	to	both	maternal	and	newborn	mtDNA	count.	Interestingly,	maternal	total	urinary	arsenic	levels	were	associated	with	infant	mtDNA	count	(β	=	-0.5894	and	p-value<0.0001)	(Figure	2),	but	not	maternal	mtDNA	count.	Neither	drinking	water	arsenic	nor	infant	plasma	arsenic	levels	were	associated	with	mtDNA	count	(Table	2).	These	data	suggests	that	as	prenatal	arsenic	exposure	increased,	mtDNA	content	in	newborn	DNA	decreased	and	that	maternal	processing	of	arsenic	is	important	in	the	effects	of	fetal	mtDNA	count.	
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Table	2.	Description	of	all	arsenic	measures	versus	leukocyte	mtDNA	counts	for	mother	and	newborn.			 Maternal	mtDNA	count	 Newborn	mtDNA	count		Drinking	Water	Arsenic	 β	=	0.002365	
p-value=	0.2675	 β	=	2.288	p-value=	0.4479	Maternal	Urinary	Arsenic	 β	=	-0.007820	
p-value=	0.2374	 β	=	-0.5894	p-value<0.0001	Infant	Plasma	Arsenic	 --	 β	=	-0.1498	
p-value=	0.1715		
	
Figure	2.	Newborn	cord	blood	leukocyte	mtDNA	copy	number	versus	maternal	urinary	total	arsenic.	Log-transformed	newborn	cord	blood	leukocyte	mtDNA	copy	numbers	are	plotted	against	log-transformed	maternal	urinary	total	arsenic	levels.	
Newborn	Cord	Blood	Leukocyte	mtDNA	Content	Displayed	an	82%	Reduction	in	
Comparison	to	Maternal	Urinary	Total	Arsenic	The	data	shown	in	Figure	3	highlight	that	in	the	lowest	quartile	of	arsenic	exposure,	the	average	mtDNA	content	was	6.53,	with	a	standard	deviation	of	0.77,	while	at	the	highest	quartile	of	exposure,	the	mtDNA	content	was	4.799,	with	a	standard	deviation	of	0.749.	From	this,	we	calculated	an	82.29	percent	reduction	in	mtDNA	copy	number	from	the	first	to	the	last	quartile.	We	conclude	that	when	arsenic	levels	increase	from	quartile	
	14	
one	(mean=	10.56	µg/L,	range=	4.33-15.05	µg/L)	to	quartile	four	(mean=	88.74	µg/L,	range=	39.5-319.74	µg/L),	mtDNA	content	decreases	by	82.29%.	
	
Figure	3.	Newborn	cord	blood	leukocyte	mtDNA	copy	number	versus	maternal	urinary	total	arsenic.	Log-transformed	newborn	cord	blood	leukocyte	mtDNA	copy	numbers	are	plotted	against	quartiles	of	log-transformed	maternal	urinary	total	arsenic	levels.	
20	Infants	Contained	Genome	Wide	Expression	Data	We	are	fortunate	with	this	cohort	to	have	data	from	gene	expression	that	was	collected	for	the	infants	at	birth	(n=38).	Of	the	infants	that	had	data	representing	genome-wide	gene	expression,	20	of	the	infants	in	our	study	had	also	been	profiled	for	mtDNA.	To	determine	whether	mtDNA	copy	number	was	associated	was	the	altered	expression	of	genes,	we	preformed	multivariable	regression	modeling	between	the	content	of	mtDNA	in	fetal	leukocytes	across	53,617	genes.	Interestingly	a	total	of	767	of	genes	displayed	significant	association	between	mtDNA	content	and	gene	expression.	The	expression	of	some	genes	increased,	while	the	expression	of	others	decreased	(Appendix	Table	1).			 	
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Mitochondrial	DNA	Copy	Number	is	associated	with	Increased	Indicators	of	Reactive	
Oxygen	Species	in	the	Newborn		Interestingly,	among	the	genes	that	showed	association	between	gene	expression	and	mtDNA	were	genes	that	encode	for	proteins	that	play	a	role	in	ROS.	We	found	that	the	expression	of	Peroxiredoxin	5	(PRDX5),	Peroxiredoxin	6	(PRDX6),	and	Glutathione	S-transferase	pi	1	(GSTP1)	was	associated	with	mtDNA	copy	number.	All	three	ROS	associated	genes	displayed	a	negative	association	with	mtDNA	content	(Figure	4,	Figure	5,	
Figure	6).	For	example,	PRDX5	is	an	endogenous	antioxidant	involved	in	the	protection	against	diseases	characterized	by	oxidative	stress,	and	has	a	significant	negative	association	(p-value=	0.0025,	R2=	0.3899)	with	mtDNA	copy	number	in	the	newborn.		
	
Figure	4.	Gene	expression	for	PRDX5	versus	log	transformed	newborn	cord	blood	leukocyte	mtDNA	copy	number.	Significant	association	demonstrates	a	negative	relationship	between	PRDX5	expression	and	mtDNA	copy	number	in	the	newborn.		
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Figure	5.	Gene	expression	for	PRDX6	versus	log	transformed	newborn	cord	blood	leukocyte	mtDNA	copy	number.	Significant	association	demonstrates	a	negative	relationship	between	PRDX6	expression	and	mtDNA	copy	number	in	the	newborn.		
	
Figure	6.	Gene	expression	for	GSTP1	versus	log	transformed	newborn	cord	blood	leukocyte	mtDNA	copy	number.	Significant	association	demonstrates	a	negative	relationship	between	GSTP1	expression	and	mtDNA	copy	number	in	the	newborn.	
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Mitochondrial	DNA	Copy	Number	is	associated	with	Key	Genes	that	are	Perturbed	by	
Prenatal	Arsenic	Exposure	in	the	Newborn		Among	the	genes	that	displayed	altered	expression	were	also	genes	that	have	been	shown	to	be	responsive	to	arsenic	exposure	(Laine	&	Fry,	2016).	Specifically,	22	previously	identified	arsenic-associated	genes	were	associated	with	mtDNA	copy	number	(Table	3).	Some	of	these	genes	displayed	a	positive	association	between	increased	mtDNA	copy	number,	while	others	displayed	a	negative	association.	For	example,	Cysteine	rich	transmembrane	BMP	regulator	1	(CRIM1)	showed	increased	gene	expression	to	mtDNA	copy	number.	This	gene	has	previously	been	shown	to	be	induced	by	arsenic	exposure,	and	plays	a	role	in	the	regulation	of	cell	growth	(Bailey	et	al.,	2014).																									
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Table	3.	Arsenic	associated	genes	with	significant	association	to	mtDNA	copy	number	in	the	newborn.	
Gene	Symbol	 Full	Gene	Name	 R	 p-value	
CRIM1	 cysteine	rich	transmembrane	BMP	regulator	1	(chordin-like)	 0.743978	 0.00011044	
B3GNT5	 UDP-GlcNAc:betaGal	beta-1,3-N-acetylglucosaminyltransferase	5	 -0.625077	 0.00244686	
CD44	 CD44	molecule	(Indian	blood	group)	 -0.565554	 0.00754045	
UCK1	 uridine-cytidine	kinase	1	 0.556897	 0.00873362	
MDC1	 mediator	of	DNA-damage	checkpoint	1	 0.544144	 0.0107693	
BTNL8	 butyrophilin-like	8	 -0.526218	 0.0142692	
ENC1	 ectodermal-neural	cortex	(with	BTB-like	domain)	 0.525335	 0.0144629	
KLHL28	 kelch-like	28	(Drosophila)	 0.503986	 0.0198317	
TXLNG	 Taxilin	Gamma	 0.494676	 0.0226245	
ZNF600	 zinc	finger	protein	600	 0.480607	 0.0274303	
CYTH4	 cytohesin	4	 -0.47455	 0.029733	
FGF19	 fibroblast	growth	factor	19	 -0.472754	 0.0304445	
RPS6KA2	 ribosomal	protein	S6	kinase,	90kDa,	polypeptide	2	 -0.468801	 0.0320576	
H3F3B	 H3	histone,	family	3B	(H3.3B);	H3	histone,	family	3A	pseudogene	 -0.46452	 0.0338793	
IFNG	 interferon,	gamma	 0.455591	 0.0379403	
EXT1	 exostoses	(multiple)	1	 -0.455381	 0.0380401	
MFAP3	 microfibrillar-associated	protein	3	 0.45231	 0.0395243	
MIR4292	 MicroRNA	4292	 0.443789	 0.0438789	
CREM	 cAMP	responsive	element	modulator	 0.438579	 0.0467196	
C2orf57	 chromosome	2	open	reading	frame	57	 -0.434613	 0.0489749	
MXD1	 MAX	dimerization	protein	1	 -0.434463	 0.0490619	
D2HGDH	 D-2-hydroxyglutarate	dehydrogenase	 0.433728	 0.0494897	
Pathway	Enrichment	Analysis	of	Predicted	Targets.		Analysis	of	enrichment	for	binding	sites	for	transcription	factors	among	genes	with	differential	expression	associated	with	mtDNA	content	were	analyzed	using	GSEA.	This	analysis	revealed	enrichment	for	binding	sites	for	three	transcription	factors	with	enriched	binding	sites	in	the	sequences:	Specificity	Protein	1	(SP1),	ELK1,	ETS	Transcription	Factor	(ELK1),	and	Transcription	Factor	3	(E12)	(Table	4).	Among	these,	the	top	transcriptional	regulator	for	our	genes	was	SP1	(p-value=	7.09x10-17,	q-value=	1.54x10-13).		The	protein	
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encoded	by	this	gene	is	involved	in	many	cellular	processes,	including	apoptosis	and	response	to	DNA	damage	(Bajpai	&	Nagaraju,	2017).			
Table	4.	Top	3	transcriptional	regulators	as	determined	by	GSEA	output.			
Gene	Set	Name	 Number	of	
Genes	
p-value	 q-value	Specificity	Protein	1	(SP1)	 94	 7.09x10-17	 1.54x10-13	ELK1,	ETS	Transcription	Factor	(ELK1)	 46	 3.24x10-11	 3.24x10-8	Transcription	Factor	3	(E12)	 72	 4.49x10-11	 3.24x10-8		 To	get	a	general	sense	of	the	biological	processes	that	displayed	altered	expression	in	relation	to	mtDNA,	we	analyzed	the	genes	for	their	biological	pathways	and	enrichment	and	identified	using	both	IPA	and	GSEA.	After	performing	enrichment	analysis,	we	identified	several	pathways	of	interest	(Table	5).	Among	these	were	processes	relating	to	cellular	and	embryonic	development	(p-value	=1.93x10-8,	q-value	=3.88x10-6),	which	was	enriched	by	33	genes	including	NKTR,	ACOT9,	and	SNAPC4.			
Table	5.	Top	5	enriched	networks	as	determined	by	IPA.	
Top	Diseases	and	
Functions	
Number	
of	Genes	
IPA	
Score	
GSEA	p-
value	
GSEA	q-
value	 Genes	in	Network	
Cellular	Development,	Cellular	Growth	and	Proliferation,	Embryonic	Development	
33	 54	 1.93x10-8	 3.88x10-6	
ACOT9,AIM2,Akt,BBS4,BRF2,DE
NND1A,EFEMP2,FBXW8,FICD,G
TPase,HSD17B11,IP6K2,KIF13B
,LURAP1,mir147,NKTR,PTP4A2,
PTP4A3,PTTG1IP,RAB40B,RAB
GGTB,RASA4,S100A16,SIGLEC9,
SLC3A2,SNAPC4,SRGAP2,TANC
2,TRIM4,TRIM41,ZMYM6,ZNF2
50,ZNF263,ZNF417/ZNF587,ZS
CAN20	
Small	Molecule	Biochemistry,	Cell	Morphology,	Cellular	Assembly	and	Organization	 28	 41	 3.19x10-8	 6.08x10-6	
ATP13A2,B3GNT5,CAPN3,CD30
0LF,CLCF1,CLEC18A/CLEC18C,
CMTM6,COQ7,COQ8B,cyclooxyg
enase,EMC7,FAM192A,FAM98A,
GCA,Iga,Ige,IgG2b,INTERLEUKI
N,JKAMP,KCND3,LMAN2,LRRC1
4,MIB2,mir-515,MRPL44,NFkB	
(complex),NFKBIL1,ORMDL3,R
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Top	Diseases	and	
Functions	
Number	
of	Genes	
IPA	
Score	
GSEA	p-
value	
GSEA	q-
value	 Genes	in	Network	
NF112,SLC2A6,SRSF10,UBE2,U
BE2J2,UBE2R2,WDR83OS	
Gene	Expression,	DNA	Replication,	Recombinatin,	and	Repair,	Cell	Cycle	 28	 41	 1.46x10-7	 2.0x10-5	
ACD,BICRAL,DNMT1,GSTP1,H2
AFV,Hdac,Histone	
h4,HNRNPC,KCNQ1OT1,KCTD1
3,KIFC1,KNDC1,MDC1,mir-
29,MXD1,N-
cor,NUP107,PAF1,PNO1,Ras,Rb,
RFWD3,RNPC3,RNU12,RPA,SM
ARCD1,snRNP,SNRPE,SNRPN,T
BCD,TBX15,USP28,WAC,ZMAT5,
ZNF518A	
Cellular	Development,	Hematological	System	Development	and	Function,	Hereditary	Disorder	
26	 37	 1.58x10-7	 2.06x10-5	
ANKRD11,ATAD3B,BORCS5,Cas
pase	
3/7,CASQ1,CCDC88B,COPRS,cyt
ochrome	
C,ERN2,FAAH,Hsp27,Jnk,L3MBT
L1,LACTB,MAGEC2,MAP2K4/7,
MAP3K4,MED28,mediator,NDU
FAF3,NSMCE4A,PARP,PARP11,
PARP12,PARP16,PPAN-
P2RY11,PSENEN,Ribosomal	40s	
subunit,RNF166,Rnr,RPS2,RPS1
1,RPS25,TRIO,ZNF324	
Carbohydrate	Metabolism,	Small	Molecule	Biochemistry,	Post-Translational	Modification	
25	 35	 8.96x10-9	 2.12	x	10	-6	
Adaptor	protein	1,ANAPC15,ANGPT4,atypical	protein	kinase	C,carboxylic	ester	hydrolase,CCDC6,Cofilin,ENC1,ERK1/2,EXT1,FKBPL,GOLIM4,HS2ST1,IL-1R,LAMTOR4,LOXL3,MAP7,MNK1/2,MSH5,NADSYN1,NDST1,NECTIN1,NRG	(family),P-TEFb,PRDX5,PRDX6,SIDT2,SSH1,SUFU,sulfotransferase,TARS2,TMEM132A,TXLNG,UST,ZHX2		
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Figure	7.	Top	enriched	pathway	as	determined	by	IPA.	
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CHAPTER	4.	DISCUSSION,	LIMITATIONS,	FUTURE	DIRECTIONS,	AND	CONCLUSIONS	The	goal	of	this	study	was	to	examine	the	relationship	between	prenatal	arsenic	exposure	and	mitochondrial	DNA	copy	number	in	a	population	in	Gómez	Palacio,	Mexico	with	an	established	exposure	ranging	from	below	the	limit	of	detection	(0.46	µg	As/L)	to	236.0	µg	As/L	(Laine	et	al.,	2015).	Mitochondrial	dysfunction	is	associated	with	increased	ROS	generation,	as	well	as	elevated	mtDNA	mutations,	among	other	things	(Reddy	&	Beal,	2005).		Inorganic	arsenic	is	thus	of	interest	as	a	potential	contaminant	associated	with	mitochondrial	dysfunction	as	is	not	only	associated	with	an	increased	level	of	reactive	oxygen	radicals,	but	also	increases	the	risk	of	oxidative	stress	in	exposed	persons	(Wu	et	al.,	2001).	As	an	established	marker	of	mitochondrial	damage,	mtDNA	content	has	been	linked	to	infant	outcomes,	such	as	both	small	and	large	for	gestational	age	(Gemma	et	al.,	2006).	The	results	of	the	present	study	demonstrate	that	as	levels	of	arsenic	exposure	increased	during	pregnancy,	mtDNA	content	decreased.	Interestingly,	mtDNA	content	was	associated	with	altered	expression	of	genes	known	to	be	involved	in	ROS	and	genes	known	to	be	altered	by	arsenic	exposure.	To	our	knowledge,	this	is	among	the	first	studies	to	describe	the	relationship	between	prenatal	arsenic	exposure	and	mitochondrial	DNA	copy	number	in	a	human	population.	An	interesting	negative	association	was	observed	between	prenatal	arsenic	exposure	and	mtDNA	content	in	fetal	leukocyte	DNA.	This	trend	between	exposure	to	environmental	contaminants	and	decreases	in	mtDNA	copy	number	has	been	observed	before.	Quantitative	changes	in	mtDNA	have	been	linked	to	type	2	diabetes	and	insulin	
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resistance	(Lee	et	al.,	1998;	Song	et	al.,	2001).	Specifically,	decreased	mtDNA	content	of	white	blood	cells	has	been	shown	in	type	2	diabetes	(Choi,	Kim,	&	Pak,	2001;	Gianotti	et	al.,	2008;	Wong	et	al.,	2009)	and	breast	cancer	(Xia	et	al.,	2009;	Yu	et	al.,	2007).	Birth	outcomes	in	relation	to	changes	in	mtDNA	content	is	an	area	of	our	interest,	as	it	has	been	found	that	the	mtDNA	copy	number	was	significantly	lower	for	both	small	for	gestational	age	and	large	for	gestational	age	infants	in	comparison	to	the	mtDNA	copy	number	for	appropriate	weight	for	gestational	age	infants	(Gemma	et	al.,	2006).	Additionally,	in	utero	exposure	to	airborne	particulate	matter	with	aerodynamic	diameter	≤	10	um	(PM10)	is	associated	with	a	lower	mtDNA	content	in	placental	tissue	(Janssen	et	al.,	2012).		The	air	pollution	results	are	consistent	with	a	separate	report	on	maternal	smoking	(a	personalized	form	of	air	pollution)	and	a	lower	mtDNA	content	(Bouhours-Nouet	et	al.,	2004).	It	is	known	that	nuclear	DNA	has	more	efficient	repair	mechanisms	as	well	as	a	lower	rate	of	mutation	than	does	mtDNA	(Chistiakov,	Sobenin,	Revin,	Orekhov,	&	Bobryshev,	2014),	as	mtDNA	lacks	protective	histones,	chromatin	structure,	and	introns	(Janssen	et	al.,	2012),	as	well	as	is	in	close	proximity	to	endogenous	ROS	in	the	mitochondrial	inner	membrane	(Liu	and	Demple,	2010)	.	The	proposed	hypothesis	for	the	biological	basis	of	this	decline	is	that	as	mitochondria	are	damaged	by	environmental	insults,	in	this	case,	inorganic	arsenic,	they	lose	their	ability	to	replicate,	and	thus	DNA	content	is	reduced.	Furthermore,	it	has	been	shown	that	mutated	mtDNA	are	clonally	amplified	through	a	compensatory	mechanism	in	response	to	energy	deficiency	and	inefficient	mitochondrial	function	(Wallace,	2005).	The	increased	number	of	mitochondria	and	mtDNA	result	in	a	harmful	cycle	of	increased	ROS	formation	from	defective	cells	(Andreu	et	al.	2009).	In	time,	mtDNA	content	is	then	
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depleted	due	to	the	loss	of	bioenergetics	and	replicative	functions	of	the	defective	mitochondria,	leading	to	an	ultimate	loss	of	mitochondrial	function	(Wong	et	al.,	2009).			In	the	analysis	of	the	relationship	between	altered	gene	expression	from	newborn	cord	blood	and	mtDNA	copy	number	in	cord-derived	leukocytes,	a	total	of	3	genes	were	identified.	Among	these	were	genes	that	are	known	to	play	a	role	in	ROS.	For	example,	the	expression	of	PRDX5,	PRDX6,	and	GSTP1	decreases	as	ROS	increases.	Both	PRDX5	and	
PRDX6	are	endogenous	antioxidants	involved	in	the	protection	against	diseases	characterized	by	oxidative	stress,	and	their	expression	has	previously	been	shown	to	be	negatively	correlated	with	biomarkers	of	inflammation	(Kunze	et	al.,	2014).	It	is	hypothesized	that	PRDX’s	are	either	consumed	or	their	production	is	impaired	in	proportion	to	degree	of	oxidative	stress.	In	addition	to	these	genes,	GSTP1	was	also	identified,	which	is	a	critical	phase	II	metabolism	gene	that	plays	a	role	in	detoxification	in	the	cell	(Hayes,	Flanagan,	&	Jowsey,	2004).	Our	data	displayed	a	negative	association	between	GSTP1	expression	and	known	ROS	related	genes,	which	is	supported	by	prior	work	which	revealed	that	decreased	GSTP1	expression	is	involved	in	the	imbalance	of	oxidant	and	anti-oxidant	in	human	hepatocellular	carcinoma	cases	(Li	et	al.,	2013).		The	genes	identified	were	not	limited	to	ROS,	but	also	many	have	been	shown	to	be	altered	by	arsenic	exposure	previously	(Laine	et	al.,	2016).	In	this	study,	a	total	of	22	genes	to	be	altered	by	arsenic	exposure	were	identified.	For	example,	in	the	present	study,	CRIM1	showed	increased	gene	expression	to	mtDNA	copy	number.		In	a	prior	study,	this	gene	has	been	induced	by	arsenic	exposure	plays	a	role	in	the	regulation	of	cell	growth	(Bailey	et	al.,	2014).	Lastly,	pathway	analysis	identified	the	top	enriched	network	as	cellular	development,	growth	and	proliferation/embryonic	development,	suggesting	the	potential	
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importance	of	the	broader	set	of	mtDNA-associated	genes	to	fetal	development.		The	functional	consequence	of	altered	gene	expression	associated	with	altered	mtDNA	copy	number	should	be	evaluated	in	the	future.	The	study	is	not	without	limitations.	While	we	have	identified	that	prenatal	arsenic	exposure	is	associated	with	mtDNA	copy	number,	the	exact	mechanism	for	this	is	unknown.	It	is	hypothesized	that	the	negative	association	is	a	result	of	arsenic’s	ability	to	damage	mitochondria,	and	reducing	their	ability	to	replicate.	This	loss	of	replicative	function	leads	to	a	depletion	of	mtDNA	content	and	an	ultimate	loss	of	mitochondrial	function	(Wong	et	al.,	2009).	Still,	future	research	should	focus	on	determining	the	mechanistic	basis	for	this	association.	A	second	limitation	of	the	work	is	that	the	impact	of	mtDNA	content	on	functional	outcome	of	children’s	health	was	not	studied	here.	While	we	did	not	find	any	association	with	mtDNA	and	birth	outcomes	this	could	be	a	function	of	sample	size	and	thus	future	research	should	seek	to	establish	the	relationship	between	birth	outcomes	and	mtDNA	levels	related	to	arsenic	exposure.		In	summary,	we	conclude	that	prenatal	arsenic	exposure	is	negatively	associated	with	mtDNA	content	in	infant	leukocytes,	and	that	mtDNA	content	is	associated	with	altered	expression	of	genes	known	to	be	involved	responding	to	cellular	ROS	and	genes	known	to	be	altered	by	arsenic	exposure.	This	research	is	among	the	first	to	examine	the	relationship	between	prenatal	arsenic	exposure	and	mtDNA	copy	number.	It	supports	several	other	reports	that	environmental	toxicant	exposure	in	human	populations	is	associated	with	decreased	mtDNA	copy	number.	In	the	present	study	we	demonstrate	that	the	mitochondria	are	indeed	harmed	by	prenatal	arsenic	exposure,	as	shown	through	a	decrease	in	mtDNA	content	and	altered	expression	of	ROS	and	arsenic	related	genes.	
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Further,	the	altered	gene	expression	profiles	are	associated	with	cellular	and	embryonic	developmental	pathways,	suggesting	an	important	role	for	mitochondria	as	a	driver	of	in	
utero	iAs	exposure-related	toxicity.		
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APPENDIX:	SUPPLEMENTAL	TABELS	
Appendix	Table	1.	All	mtDNA	associated	genes:	20	infants	contain	genome	wide	gene	expression	data.	
Gene	Symbol	 r	 p-value(correlation)	
q-value	
(p-value(correlation))	
CRIM1		 0.743978	 0.00011044	 0.998676	
AIM2		 0.728011	 0.000183146	 0.998676	
SOLH		 0.724107	 0.000206176	 0.998676	
S100A16		 0.716973	 0.000254738	 0.998676	
OR4K14		 -0.713333	 0.000283089	 0.998676	
WDR91		 -0.700786	 0.000402557	 0.998676	
MFSD1		 -0.678102	 0.000729235	 0.998676	
RNA5SP139		 -0.676388	 0.000761167	 0.998676	
PTP4A2		 -0.675658	 0.000775118	 0.998676	
MIR4642		 -0.675392	 0.000780248	 0.998676	
NOXRED1		 -0.666009	 0.00098101	 0.998676	
PTGER2		 0.661005	 0.00110491	 0.998676	
IL11RA		 0.656271	 0.00123409	 0.998676	
LIM2		 0.655488	 0.00125664	 0.998676	
LOC100507530		 -0.655202	 0.00126496	 0.998676	
NOL12		 0.654236	 0.00129341	 0.998676	
LINC00173		 -0.65362	 0.00131184	 0.998676	
TMEM114		 -0.649546	 0.0014394	 0.998676	
FLJ11235		 0.647225	 0.00151663	 0.998676	
RBM10		 0.64449	 0.00161213	 0.998676	
KCNQ1OT1		 -0.642844	 0.00167202	 0.998676	
MAP7		 -0.638352	 0.00184503	 0.998676	
OTTHUMG00000163338			 0.634678	 0.00199754	 0.998676	
OTTHUMG00000151591			 0.630508	 0.00218333	 0.998676	
FBXL14		 0.627865	 0.00230844	 0.998676	
LOC649133		 -0.626855	 0.00235782	 0.998676	
ZMAT5		 -0.626244	 0.00238812	 0.998676	
B3GNT5		 -0.625077	 0.00244686	 0.998676	
PRDX5		 -0.624412	 0.0024809	 0.998676	
ACD		 0.621357	 0.00264239	 0.998676	
PSENEN		 -0.621318	 0.00264452	 0.998676	
TRIM64B		 0.619774	 0.0027295	 0.998676	
GTF2H1		 0.618859	 0.00278091	 0.998676	
TTC38		 0.618126	 0.00282266	 0.998676	
MAPK9		 0.617536	 0.00285669	 0.998676	
SLC22A20		 -0.617116	 0.00288113	 0.998676	
SPATA31A4		 -0.616507	 0.00291684	 0.998676	
CBWD3		 -0.616361	 0.00292546	 0.998676	
RAB40B		 0.614406	 0.00304286	 0.998676	
NUFIP1		 0.613557	 0.00309511	 0.998676	
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Gene	Symbol	 r	 p-value(correlation)	
q-value	
(p-value(correlation))	
PPIAP30		 0.612695	 0.00314885	 0.998676	
VPS9D1		 0.610452	 0.00329251	 0.998676	
BRF2		 0.609705	 0.00334154	 0.998676	
SNHG1		 -0.608844	 0.00339881	 0.998676	
FER		 -0.608597	 0.00341537	 0.998676	
GRWD1		 0.608141	 0.00344617	 0.998676	
SUZ12P1		 -0.605549	 0.00362557	 0.998676	
MKNK1		 -0.605404	 0.00363583	 0.998676	
ANKRD10-IT1		 -0.605017	 0.00366332	 0.998676	
RTN4RL1		 -0.60397	 0.0037386	 0.998676	
LYPLAL1		 -0.603223	 0.00379311	 0.998676	
TMEM5		 -0.603093	 0.00380268	 0.998676	
LOC100130071		 -0.602142	 0.00387312	 0.998676	
HCRTR1		 -0.600086	 0.00402929	 0.998676	
SNORD121B		 -0.598738	 0.00413444	 0.998676	
SLC25A13		 -0.598405	 0.00416076	 0.998676	
LOC100506713		 -0.598233	 0.00417445	 0.998676	
ZMYND10-AS1		 0.596732	 0.00429515	 0.998676	
MIR29C		 -0.596368	 0.00432491	 0.998676	
SCN4B		 0.596043	 0.0043516	 0.998676	
OR52B6		 -0.595121	 0.00442796	 0.998676	
PAN2		 0.592321	 0.0046669	 0.998676	
PRND		 -0.591535	 0.00473588	 0.998676	
ENO1		 -0.590504	 0.00482762	 0.998676	
NANP		 0.59013	 0.00486125	 0.998676	
MIR147A		 -0.589994	 0.00487354	 0.998676	
ERLIN2		 0.588687	 0.00499291	 0.998676	
ENTPD4		 0.588421	 0.00501752	 0.998676	
GTSF1		 -0.588229	 0.00503535	 0.998676	
DND1		 0.588029	 0.00505393	 0.998676	
OASL		 0.587521	 0.00510141	 0.998676	
GAGE12C		 0.58739	 0.00511374	 0.998676	
TMEM234		 0.58687	 0.00516287	 0.998676	
RNA5SP65		 -0.58636	 0.00521145	 0.998676	
LINC00885		 0.585862	 0.00525922	 0.998676	
LCAT		 -0.585612	 0.00528334	 0.998676	
NPR2		 0.584776	 0.00536466	 0.998676	
SRM		 0.583566	 0.00548419	 0.998676	
SURF2		 0.583506	 0.00549018	 0.998676	
KIAA0754		 -0.583505	 0.00549026	 0.998676	
PTP4A3		 -0.583279	 0.00551285	 0.998676	
LILRB4		 -0.582601	 0.00558101	 0.998676	
SNORA11D			 0.582366	 0.00560491	 0.998676	
TRIM78P		 -0.581469	 0.00569654	 0.998676	
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Gene	Symbol	 r	 p-value(correlation)	
q-value	
(p-value(correlation))	
FAM127B		 0.580701	 0.00577596	 0.998676	
CASQ1		 0.580172	 0.00583122	 0.998676	
MIR433		 -0.579069	 0.00594786	 0.998676	
GDPGP1		 0.578702	 0.00598718	 0.998676	
CMAHP		 0.577063	 0.00616498	 0.998676	
PLA2G2C		 -0.576021	 0.00628025	 0.998676	
ING5		 -0.575795	 0.0063055	 0.998676	
SEMA5A		 0.574877	 0.00640891	 0.998676	
ABCA2		 0.574774	 0.00642058	 0.998676	
LOC100128172		 0.573944	 0.00651539	 0.998676	
VCAN-AS1		 -0.573138	 0.00660862	 0.998676	
PARP11		 -0.571946	 0.00674842	 0.998676	
UPB1		 0.570407	 0.00693253	 0.998676	
PEX6		 0.569966	 0.00698608	 0.998676	
ZNF439		 0.569782	 0.00700857	 0.998676	
CLDND2		 0.56976	 0.00701116	 0.998676	
WNT3A		 0.568408	 0.00717787	 0.998676	
CFD		 -0.567989	 0.00723022	 0.998676	
ZNF90		 -0.567223	 0.00732671	 0.998676	
RNA5SP486		 0.566799	 0.00738051	 0.998676	
TMEM163		 -0.566792	 0.00738136	 0.998676	
DVL3		 0.566784	 0.00738237	 0.998676	
PBX4		 -0.566147	 0.00746396	 0.998676	
PEX7		 -0.565729	 0.0075179	 0.998676	
CD44		 -0.565554	 0.00754045	 0.998676	
ZSCAN20		 -0.565439	 0.00755544	 0.998676	
HSPA9		 0.563589	 0.00779884	 0.998676	
MIR181A2		 0.563208	 0.00784973	 0.998676	
FAM192A		 -0.563007	 0.00787674	 0.998676	
PER2		 0.562123	 0.00799621	 0.998676	
H6PD		 0.561758	 0.00804606	 0.998676	
RARRES2		 0.561545	 0.00807514	 0.998676	
PINLYP		 0.561314	 0.00810694	 0.998676	
FAAH		 -0.559086	 0.00841818	 0.998676	
CRY2		 0.558885	 0.00844681	 0.998676	
LOC728145		 0.558667	 0.00847782	 0.998676	
ZCCHC17		 0.558234	 0.00853983	 0.998676	
RPS25		 -0.557696	 0.00861745	 0.998676	
MED28		 -0.557599	 0.0086315	 0.998676	
UCK1		 0.556897	 0.00873362	 0.998676	
MVD		 0.556794	 0.00874874	 0.998676	
TOR2A		 0.556196	 0.00883666	 0.998676	
KCTD13		 0.556169	 0.00884068	 0.998676	
H1FX-AS1		 0.555333	 0.00896484	 0.998676	
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Gene	Symbol	 r	 p-value(correlation)	
q-value	
(p-value(correlation))	
ACTN1-AS1		 0.555199	 0.00898484	 0.998676	
CBWD5		 -0.553421	 0.0092542	 0.998676	
OTTHUMG00000018686			 -0.553291	 0.0092742	 0.998676	
GALNT12		 0.553189	 0.0092899	 0.998676	
HABP4		 0.552933	 0.0093293	 0.998676	
ERVK3-1		 0.552157	 0.00944981	 0.998676	
FZD6		 0.551889	 0.00949165	 0.998676	
FKBP2		 0.551503	 0.00955218	 0.998676	
GPR62		 0.549708	 0.00983819	 0.998676	
LINC00638		 0.548901	 0.00996908	 0.998676	
PARP16		 -0.54848	 0.0100379	 0.998676	
CCDC6		 -0.547434	 0.0102105	 0.998676	
AHCY		 -0.547288	 0.0102346	 0.998676	
SCRN3		 -0.547109	 0.0102646	 0.998676	
LOXL3		 0.546918	 0.0102964	 0.998676	
OTTHUMG00000035804			 0.546888	 0.0103014	 0.998676	
LMBR1		 -0.546653	 0.0103409	 0.998676	
ACOT9		 -0.546632	 0.0103444	 0.998676	
SNRPN		 -0.546178	 0.0104209	 0.998676	
LOC100506048		 0.545488	 0.010538	 0.998676	
OTTHUMG00000164174			 0.545112	 0.0106023	 0.998676	
UNKL		 0.545109	 0.0106028	 0.998676	
STAT4		 0.544322	 0.0107384	 0.998676	
MDC1		 0.544144	 0.0107693	 0.998676	
RNA5SP462		 -0.543727	 0.0108419	 0.998676	
ZDHHC11		 0.543558	 0.0108714	 0.998676	
INSIG2		 -0.542953	 0.0109776	 0.998676	
CLEC18C		 0.54269	 0.0110241	 0.998676	
OSER1-AS1		 0.542678	 0.0110263	 0.998676	
RAP1B		 -0.542362	 0.0110823	 0.998676	
PPP1R12C		 0.541992	 0.0111482	 0.998676	
KLHL17		 -0.541859	 0.0111718	 0.998676	
EXOC3L1		 0.541293	 0.0112734	 0.998676	
LURAP1		 0.541031	 0.0113207	 0.998676	
C2orf42		 0.541018	 0.0113231	 0.998676	
ARFGAP2		 0.540425	 0.0114308	 0.998676	
OSGEP		 -0.540084	 0.0114931	 0.998676	
RHBDF2		 0.539988	 0.0115106	 0.998676	
KBTBD11		 0.539014	 0.0116902	 0.998676	
L3MBTL1		 0.538522	 0.0117818	 0.998676	
MPP5		 -0.538089	 0.011863	 0.998676	
ATAT1		 0.537681	 0.0119397	 0.998676	
ATAT1		 0.537681	 0.0119397	 0.998676	
ATAT1		 0.537681	 0.0119397	 0.998676	
	31	
Gene	Symbol	 r	 p-value(correlation)	
q-value	
(p-value(correlation))	
ATAT1		 0.537681	 0.0119397	 0.998676	
ATAT1		 0.537681	 0.0119397	 0.998676	
ATAT1		 0.537681	 0.0119397	 0.998676	
ZNF263		 0.537396	 0.0119937	 0.998676	
NFKBIL1		 0.537095	 0.0120509	 0.998676	
DUS3L		 0.53694	 0.0120804	 0.998676	
SNORD116-10		 0.536295	 0.0122037	 0.998676	
LOC100506801		 -0.53618	 0.0122259	 0.998676	
RPS2		 -0.535883	 0.012283	 0.998676	
FBXW8		 0.53536	 0.0123844	 0.998676	
RABGGTB		 -0.534324	 0.0125874	 0.998676	
TMEM132A		 0.533309	 0.0127887	 0.998676	
CALHM1		 0.533114	 0.0128276	 0.998676	
ZXDA		 -0.533094	 0.0128316	 0.998676	
WHAMM		 0.532997	 0.0128511	 0.998676	
ZCCHC5		 -0.532897	 0.012871	 0.998676	
LAYN		 0.532878	 0.0128749	 0.998676	
PTTG1IP		 -0.532682	 0.0129143	 0.998676	
RPL23AP53		 0.53237	 0.0129773	 0.998676	
RAB5C		 -0.531753	 0.0131023	 0.998676	
TMEM91		 -0.53149	 0.0131559	 0.998676	
NADSYN1		 0.530119	 0.0134384	 0.998676	
RHOBTB2		 0.529923	 0.0134793	 0.998676	
FAM173A		 0.529543	 0.0135586	 0.998676	
ARL16		 0.529129	 0.0136455	 0.998676	
SMG9		 0.529101	 0.0136513	 0.998676	
ZNF737		 -0.528893	 0.0136952	 0.998676	
NR5A1		 -0.528671	 0.0137421	 0.998676	
OTTHUMG00000149070			 0.527107	 0.0140764	 0.998676	
ZHX2		 -0.526654	 0.0141743	 0.998676	
SRGAP2		 -0.526275	 0.0142568	 0.998676	
BTNL8		 -0.526218	 0.0142692	 0.998676	
EMC7		 -0.525822	 0.0143558	 0.998676	
ENC1		 0.525335	 0.0144629	 0.998676	
LOC115110		 0.525321	 0.0144659	 0.998676	
OTTHUMG00000158962			 -0.52516	 0.0145015	 0.998676	
TSPAN13		 0.525032	 0.0145297	 0.998676	
LRRC14		 0.52489	 0.0145614	 0.998676	
COQ7		 -0.524617	 0.0146218	 0.998676	
SSH1		 0.522947	 0.0149974	 0.998676	
HCG18		 0.522456	 0.0151093	 0.998676	
SPRY2		 0.522131	 0.0151835	 0.998676	
FLJ32255		 0.522054	 0.0152013	 0.998676	
CST9L		 -0.521139	 0.0154124	 0.998676	
	32	
Gene	Symbol	 r	 p-value(correlation)	
q-value	
(p-value(correlation))	
ZNF333		 0.521103	 0.015421	 0.998676	
NOXO1		 -0.520038	 0.0156698	 0.998676	
APOBR		 -0.51957	 0.0157804	 0.998676	
CLDN19		 -0.518641	 0.0160014	 0.998676	
DPY19L2P2		 0.518625	 0.0160051	 0.998676	
NFKBIL1		 0.518414	 0.0160558	 0.998676	
NFKBIL1		 0.518414	 0.0160558	 0.998676	
NFKBIL1		 0.518414	 0.0160558	 0.998676	
NFKBIL1		 0.518414	 0.0160558	 0.998676	
NOC4L		 0.518357	 0.0160695	 0.998676	
EHD2		 0.518272	 0.0160898	 0.998676	
ZNF324		 -0.517947	 0.0161682	 0.998676	
OTTHUMG00000163965			 0.517893	 0.0161813	 0.998676	
ETFA		 -0.517646	 0.0162409	 0.998676	
ALPK1		 -0.516804	 0.016446	 0.998676	
LOC391322		 -0.51664	 0.0164861	 0.998676	
SNRPN		 0.516284	 0.0165735	 0.998676	
MIB2		 0.516256	 0.0165804	 0.998676	
MIR4638		 0.516066	 0.0166272	 0.998676	
H2AFV		 0.515976	 0.0166495	 0.998676	
DNAJC3-AS1		 -0.515747	 0.0167062	 0.998676	
PET112		 0.515656	 0.0167287	 0.998676	
TRIO		 0.515502	 0.0167669	 0.998676	
ZNF497		 0.515466	 0.0167758	 0.998676	
YPEL1		 0.515042	 0.0168815	 0.998676	
LOXHD1		 0.51479	 0.0169446	 0.998676	
RFWD3		 0.514526	 0.0170109	 0.998676	
CLEC4F		 -0.514315	 0.017064	 0.998676	
SHISA8		 0.513876	 0.017175	 0.998676	
SPCS1		 -0.513446	 0.0172841	 0.998676	
RBCK1		 0.51305	 0.0173851	 0.998676	
PDE9A		 -0.512582	 0.0175052	 0.998676	
ARPC5L		 0.512069	 0.0176376	 0.998676	
GAGE12C		 0.511723	 0.0177275	 0.998676	
GAGE12C		 0.511723	 0.0177275	 0.998676	
GAGE12C		 0.511723	 0.0177275	 0.998676	
THAP4		 -0.51106	 0.0179003	 0.998676	
TRIM41		 0.510227	 0.0181197	 0.998676	
LOC100128002		 0.509662	 0.0182696	 0.998676	
AASDHPPT		 -0.50953	 0.0183046	 0.998676	
CLASRP		 0.509434	 0.0183303	 0.998676	
SRGAP2-AS1		 -0.509048	 0.0184336	 0.998676	
ANKRD18A		 0.509038	 0.0184364	 0.998676	
IP6K2		 0.508658	 0.0185384	 0.998676	
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PTEN		 -0.508394	 0.0186096	 0.998676	
SPAG9		 -0.508259	 0.0186462	 0.998676	
COL18A1-AS1		 0.507847	 0.018758	 0.998676	
CPT1A		 0.507598	 0.0188256	 0.998676	
AGBL2		 0.507128	 0.0189544	 0.998676	
SNORD11		 0.50648	 0.0191326	 0.998676	
LOC389332		 0.506412	 0.0191516	 0.998676	
LOC148696		 0.506354	 0.0191675	 0.998676	
MIR1301		 0.506333	 0.0191732	 0.998676	
ZNF429		 0.506241	 0.0191989	 0.998676	
RNU12		 0.506225	 0.0192033	 0.998676	
ZMYM6		 -0.506101	 0.0192376	 0.998676	
OTTHUMG00000169787			 0.505957	 0.0192775	 0.998676	
ZNF619		 0.505938	 0.0192829	 0.998676	
PTPRN		 -0.505818	 0.0193164	 0.998676	
PRAMEF16		 -0.505272	 0.0194688	 0.998676	
ANXA2P2		 -0.505249	 0.0194752	 0.998676	
ZNF542		 -0.505129	 0.0195089	 0.998676	
LACTB		 -0.5051	 0.0195171	 0.998676	
TBCD		 0.504803	 0.0196005	 0.998676	
MAK		 -0.50474	 0.0196184	 0.998676	
DNMT1		 0.504555	 0.0196706	 0.998676	
PYGB		 -0.50434	 0.0197314	 0.998676	
SNORD116-27		 0.504093	 0.0198014	 0.998676	
KLHL28		 0.503986	 0.0198317	 0.998676	
ANKRA2		 -0.503644	 0.0199292	 0.998676	
GTF2A1		 -0.503614	 0.0199379	 0.998676	
CBWD1		 -0.503549	 0.0199565	 0.998676	
HNRNPC		 -0.502893	 0.0201446	 0.998676	
COBLL1		 0.502876	 0.0201496	 0.998676	
COL4A3BP		 -0.502837	 0.0201608	 0.998676	
KCND3		 0.502822	 0.0201651	 0.998676	
RNA5SP70		 -0.502357	 0.0202993	 0.998676	
RPS11		 -0.502225	 0.0203378	 0.998676	
GZMA		 0.502083	 0.0203788	 0.998676	
IGSF8		 0.501977	 0.0204097	 0.998676	
UBE2R2		 -0.501975	 0.0204104	 0.998676	
KATNAL2		 0.501888	 0.0204356	 0.998676	
AAMP		 -0.501787	 0.0204652	 0.998676	
SUFU		 0.501748	 0.0204764	 0.998676	
C9orf169		 0.501411	 0.0205749	 0.998676	
WASH4P		 0.501288	 0.0206111	 0.998676	
USP28		 0.500548	 0.0208288	 0.998676	
TGFA-IT1		 -0.500492	 0.0208455	 0.998676	
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OTTHUMG00000172076			 -0.500295	 0.0209038	 0.998676	
UBTD1		 -0.499976	 0.0209987	 0.998676	
LOC100129034		 -0.499872	 0.0210297	 0.998676	
CHTOP		 -0.499801	 0.0210507	 0.998676	
MIR3918		 0.499648	 0.0210965	 0.998676	
APOL2		 0.499418	 0.0211652	 0.998676	
LOC100303749		 -0.499238	 0.0212193	 0.998676	
ZMIZ2		 0.498689	 0.0213844	 0.998676	
SLFN13		 0.498522	 0.0214352	 0.998676	
RABL6		 0.498273	 0.0215106	 0.998676	
MIR4640			 0.498056	 0.0215765	 0.998676	
HOMER1		 0.498012	 0.0215899	 0.998676	
OTTHUMG00000164332			 0.497461	 0.021758	 0.998676	
UST		 0.497066	 0.0218792	 0.998676	
KIF13B		 0.496993	 0.0219017	 0.998676	
KIN		 -0.496715	 0.0219874	 0.998676	
DDC		 -0.496499	 0.0220543	 0.998676	
PHPT1		 -0.496328	 0.0221072	 0.998676	
WDR83OS		 -0.49627	 0.0221253	 0.998676	
MIR4772		 0.49616	 0.0221593	 0.998676	
SLC3A2		 -0.495778	 0.0222784	 0.998676	
LACE1		 0.495758	 0.0222845	 0.998676	
ID4		 0.495733	 0.0222924	 0.998676	
TMEM186		 -0.495448	 0.0223815	 0.998676	
LOC650368		 0.495383	 0.022402	 0.998676	
LOC100506191		 -0.495174	 0.0224674	 0.998676	
BAIAP2		 0.494964	 0.0225337	 0.998676	
TXLNG		 0.494676	 0.0226245	 0.998676	
ANKRD11		 0.49404	 0.0228259	 0.998676	
ZBTB40-IT1		 0.493488	 0.0230023	 0.998676	
RABAC1		 -0.493191	 0.0230976	 0.998676	
PAQR4		 0.493114	 0.0231223	 0.998676	
OTTHUMG00000166666			 -0.492845	 0.0232089	 0.998676	
IREB2		 0.492636	 0.0232763	 0.998676	
C6orf48		 -0.492511	 0.0233166	 0.998676	
OTTHUMG00000173008			 0.492201	 0.0234171	 0.998676	
LOC389641		 -0.492012	 0.0234787	 0.998676	
DBH		 0.49171	 0.023577	 0.998676	
RNU7-77P		 0.491589	 0.0236167	 0.998676	
UBE2J2		 0.491436	 0.0236666	 0.998676	
U2AF1		 -0.4914	 0.0236784	 0.998676	
SCARNA5			 0.491387	 0.0236827	 0.998676	
CELSR2		 -0.491369	 0.0236887	 0.998676	
SNAPC4		 0.491137	 0.0237647	 0.998676	
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TMEM167B		 -0.490876	 0.0238507	 0.998676	
SMYD4		 0.490331	 0.0240307	 0.998676	
CXorf21		 -0.490177	 0.0240817	 0.998676	
C16orf3		 0.490114	 0.0241027	 0.998676	
DOC2A		 0.489805	 0.0242057	 0.998676	
IGLC1		 -0.489766	 0.0242186	 0.998676	
ZNF789		 0.489712	 0.0242366	 0.998676	
SEC22A		 0.489664	 0.0242525	 0.998676	
ALKBH4		 0.489417	 0.0243353	 0.998676	
GAGE12H		 0.489404	 0.0243395	 0.998676	
RNF112		 0.489234	 0.0243967	 0.998676	
ZNF727		 0.488874	 0.0245177	 0.998676	
EIF3K		 -0.488838	 0.0245296	 0.998676	
OTTHUMG00000014331			 0.488221	 0.0247383	 0.998676	
ALYREF		 -0.488087	 0.0247836	 0.998676	
SLC16A8		 0.487996	 0.0248146	 0.998676	
CYP4V2		 -0.48774	 0.0249017	 0.998676	
MIR3118-4		 -0.487713	 0.0249112	 0.998676	
MIR3118-4		 -0.487713	 0.0249112	 0.998676	
CYB561D2		 -0.487437	 0.0250053	 0.998676	
WAC		 -0.487407	 0.0250157	 0.998676	
MBD3		 0.487359	 0.025032	 0.998676	
ATF5		 -0.487334	 0.0250407	 0.998676	
PRKCI		 -0.486949	 0.0251729	 0.998676	
SH3BP2		 0.486919	 0.0251832	 0.998676	
SCUBE1		 0.486742	 0.025244	 0.998676	
MIR877		 0.486547	 0.0253112	 0.998676	
MIR877		 0.486547	 0.0253112	 0.998676	
MIR877		 0.486547	 0.0253112	 0.998676	
MIR877		 0.486547	 0.0253112	 0.998676	
MIR877		 0.486547	 0.0253112	 0.998676	
MIR877		 0.486547	 0.0253112	 0.998676	
SZT2		 0.486172	 0.0254413	 0.998676	
SLC6A1		 0.486166	 0.0254433	 0.998676	
SLC15A4		 -0.48616	 0.0254454	 0.998676	
TARS2		 -0.486115	 0.0254608	 0.998676	
SLC2A6		 0.485799	 0.0255706	 0.998676	
MIR499A		 0.485514	 0.0256701	 0.998676	
SERINC2		 -0.485255	 0.0257607	 0.998676	
SNORD51		 0.485253	 0.0257614	 0.998676	
PRDX6		 -0.484686	 0.0259606	 0.998676	
OTTHUMG00000159435			 -0.484032	 0.026192	 0.998676	
MIR877		 0.483677	 0.0263181	 0.998676	
LOH12CR1		 0.483463	 0.0263946	 0.998676	
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PARP12		 0.483235	 0.0264763	 0.998676	
TMEM167A		 -0.482719	 0.0266615	 0.998676	
ITPR1-AS1		 0.482605	 0.0267023	 0.998676	
RNPC3		 -0.482382	 0.0267831	 0.998676	
ZNF438		 -0.482319	 0.0268059	 0.998676	
ZNF658		 -0.482254	 0.0268293	 0.998676	
TBCE		 0.481943	 0.0269418	 0.998676	
MAST4		 -0.481864	 0.0269705	 0.998676	
OTTHUMG00000163653			 -0.481795	 0.0269958	 0.998676	
GHRL		 -0.481542	 0.0270879	 0.998676	
NACA2		 0.481351	 0.0271573	 0.998676	
ZNF600		 0.480607	 0.0274303	 0.998676	
SNORD58A		 0.480351	 0.0275246	 0.998676	
MIR4534		 0.480095	 0.0276192	 0.998676	
GCA		 -0.480027	 0.0276445	 0.998676	
FDX1L		 -0.479694	 0.027768	 0.998676	
GSTP1		 -0.479646	 0.0277858	 0.998676	
FICD		 0.479484	 0.0278463	 0.998676	
RP5-905G11.4			 0.479206	 0.0279499	 0.998676	
SMAD4		 -0.479197	 0.0279533	 0.998676	
HPS4		 0.479085	 0.0279951	 0.998676	
ORAI2		 0.478971	 0.0280378	 0.998676	
ATAD5		 0.4789	 0.0280643	 0.998676	
KCNJ2		 -0.478818	 0.0280954	 0.998676	
LOC100506748		 -0.478539	 0.0282002	 0.998676	
ITGAV		 -0.478182	 0.0283347	 0.998676	
DNAH1		 0.47806	 0.0283808	 0.998676	
NDST1		 -0.477936	 0.0284278	 0.998676	
SETD1A		 0.477584	 0.0285612	 0.998676	
OTTHUMG00000171045			 -0.477191	 0.0287109	 0.998676	
CRB3		 0.476978	 0.0287922	 0.998676	
FLJ31306		 -0.476887	 0.0288272	 0.998676	
ANAPC15		 -0.476785	 0.0288663	 0.998676	
RNF166		 0.4764	 0.0290143	 0.998676	
OTTHUMG00000167737			 0.476368	 0.0290265	 0.998676	
ZNF823		 0.476358	 0.0290302	 0.998676	
ATAT1		 0.476098	 0.0291307	 0.998676	
TMEM143		 0.475909	 0.0292036	 0.998676	
CMTM6		 -0.475771	 0.0292569	 0.998676	
TRIM4		 -0.475651	 0.0293034	 0.998676	
LOC151171		 0.475339	 0.029425	 0.998676	
TLR2		 -0.475309	 0.0294365	 0.998676	
LGR6		 0.474675	 0.029684	 0.998676	
CYTH4		 -0.47455	 0.029733	 0.998676	
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FLJ45248		 0.474397	 0.0297932	 0.998676	
HSD3B7		 0.474326	 0.0298211	 0.998676	
OTTHUMG00000017561			 -0.474292	 0.0298346	 0.998676	
ZNF587		 -0.47377	 0.0300406	 0.998676	
AP3B1		 -0.473711	 0.0300638	 0.998676	
TMEM65		 -0.473498	 0.0301483	 0.998676	
GAPDH		 -0.473452	 0.0301666	 0.998676	
OTTHUMG00000150919			 -0.473448	 0.0301682	 0.998676	
OTTHUMG00000171652			 -0.473387	 0.0301921	 0.998676	
WBSCR27		 -0.473329	 0.0302152	 0.998676	
OR4C46		 0.473321	 0.0302187	 0.998676	
KLHL26		 -0.473252	 0.0302461	 0.998676	
LINGO2		 0.472944	 0.0303687	 0.998676	
FGF19		 -0.472754	 0.0304445	 0.998676	
OTTHUMG00000171137			 -0.472193	 0.0306697	 0.998676	
OR10AD1		 -0.472177	 0.030676	 0.998676	
MRPL15		 -0.472148	 0.0306877	 0.998676	
SRSF2		 -0.472062	 0.0307221	 0.998676	
RAMP2-AS1		 0.471953	 0.0307663	 0.998676	
C16orf98		 0.47176	 0.0308439	 0.998676	
OTTHUMG00000172206			 -0.47173	 0.030856	 0.998676	
C11orf58		 0.471534	 0.0309355	 0.998676	
LHX3		 -0.471273	 0.031041	 0.998676	
LOC730268		 0.471212	 0.0310659	 0.998676	
AACSP1		 0.471184	 0.0310775	 0.998676	
SNORA11		 0.471131	 0.0310988	 0.998676	
ZNF584		 -0.471122	 0.0311025	 0.998676	
SLC16A11		 -0.471044	 0.0311343	 0.998676	
SRP14-AS1		 0.471043	 0.0311345	 0.998676	
MIR211		 -0.470923	 0.0311835	 0.998676	
AMICA1		 -0.470833	 0.03122	 0.998676	
YJEFN3		 0.469966	 0.0315753	 0.998676	
MNAT1		 -0.469827	 0.0316326	 0.998676	
STXBP3		 -0.469762	 0.0316595	 0.998676	
RASA4		 -0.469716	 0.0316782	 0.998676	
C14orf166B		 0.469689	 0.0316895	 0.998676	
ADA		 0.469303	 0.0318489	 0.998676	
RPS6KA2		 -0.468801	 0.0320576	 0.998676	
RPL13		 -0.468691	 0.0321035	 0.998676	
DLX1		 0.468626	 0.0321305	 0.998676	
LOC100129534		 -0.468604	 0.0321398	 0.998676	
TREX1		 -0.468374	 0.0322359	 0.998676	
SIGLEC9		 -0.468355	 0.0322436	 0.998676	
SNRPE		 0.468345	 0.0322477	 0.998676	
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DENND1A		 0.468179	 0.0323173	 0.998676	
RCOR3		 -0.468096	 0.0323523	 0.998676	
SLC25A3		 -0.467629	 0.0325484	 0.998676	
PNO1		 -0.467328	 0.0326755	 0.998676	
ZNF207		 -0.467201	 0.0327291	 0.998676	
SCXA		 -0.466911	 0.0328522	 0.998676	
METTL6		 -0.46689	 0.0328609	 0.998676	
OTTHUMG00000033267			 0.466824	 0.0328892	 0.998676	
LRRC45		 0.466805	 0.0328973	 0.998676	
PCGF3		 -0.466794	 0.0329018	 0.998676	
TMEM191A		 -0.466746	 0.032922	 0.998676	
SIGLEC16		 0.466375	 0.0330801	 0.998676	
IGHV4-61			 0.466268	 0.0331258	 0.998676	
NSMCE4A		 0.466117	 0.0331905	 0.998676	
FCGR1C		 -0.465715	 0.0333628	 0.998676	
NAIF1		 0.465524	 0.0334448	 0.998676	
HS2ST1		 -0.465436	 0.033483	 0.998676	
EDEM3		 -0.465241	 0.0335671	 0.998676	
DUSP15		 0.46492	 0.0337057	 0.998676	
POLM		 -0.464886	 0.0337203	 0.998676	
CDK2AP2		 -0.464792	 0.0337612	 0.998676	
TMEM201		 0.464783	 0.033765	 0.998676	
HLA-DRA		 -0.46469	 0.0338057	 0.998676	
PROC		 0.46462	 0.0338357	 0.998676	
SNORD82		 0.464579	 0.0338539	 0.998676	
H3F3B			 -0.46452	 0.0338793	 0.998676	
FAM86C1		 -0.46451	 0.0338835	 0.998676	
LINC00523		 -0.464414	 0.0339253	 0.998676	
SNORD59A		 0.46435	 0.0339534	 0.998676	
OR8U1		 -0.464299	 0.0339755	 0.998676	
OTTHUMG00000157083			 -0.464273	 0.0339867	 0.998676	
KIFC1		 0.464146	 0.0340422	 0.998676	
GCHFR		 0.46393	 0.0341368	 0.998676	
TBX15		 -0.463899	 0.0341504	 0.998676	
NDUFAF3		 -0.463839	 0.0341767	 0.998676	
OR10G9		 -0.463695	 0.0342394	 0.998676	
FKBPL		 0.463683	 0.0342448	 0.998676	
CRYBB1		 0.463605	 0.034279	 0.998676	
TM4SF19		 0.463562	 0.0342979	 0.998676	
C21orf90		 0.46353	 0.0343119	 0.998676	
POMC		 0.462585	 0.0347289	 0.998676	
ISM1		 0.462411	 0.0348061	 0.998676	
OTTHUMG00000180685			 -0.462387	 0.0348167	 0.998676	
MUL1		 -0.462251	 0.0348775	 0.998676	
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MLLT10		 -0.461977	 0.0349996	 0.998676	
OTTHUMG00000150809			 0.461539	 0.0351952	 0.998676	
LINC00894		 0.46143	 0.035244	 0.998676	
RNF185-AS1		 0.461085	 0.0353989	 0.998676	
PGCP1		 0.461001	 0.0354369	 0.998676	
LRRC7		 -0.460868	 0.035497	 0.998676	
RASA4		 -0.460719	 0.0355643	 0.998676	
THOP1		 0.460574	 0.0356296	 0.998676	
GZMK		 0.460505	 0.0356609	 0.998676	
ANGPT4		 0.460435	 0.0356924	 0.998676	
KAT6A		 -0.460127	 0.0358324	 0.998676	
KNDC1		 0.459717	 0.036019	 0.998676	
CENPJ		 -0.459591	 0.0360765	 0.998676	
FAM98A		 0.45955	 0.0360951	 0.998676	
C19orf73		 0.459356	 0.0361839	 0.998676	
TSHZ1		 0.459314	 0.0362032	 0.998676	
FPR2		 -0.459272	 0.0362224	 0.998676	
TARDBP		 -0.459215	 0.0362486	 0.998676	
MGC16025		 -0.459185	 0.0362623	 0.998676	
ZNF837		 -0.458741	 0.0364664	 0.998676	
SUGP2		 0.458342	 0.0366505	 0.998676	
PGM3		 0.458199	 0.0367165	 0.998676	
NFKBIL1		 0.457919	 0.0368467	 0.998676	
PRSS27		 0.457914	 0.0368488	 0.998676	
MLC1		 0.457859	 0.0368743	 0.998676	
SLC2A8		 0.457799	 0.0369022	 0.998676	
TRAV8-1		 -0.457476	 0.0370527	 0.998676	
SUN5		 0.457376	 0.0370992	 0.998676	
GNPDA1		 0.457323	 0.0371241	 0.998676	
SMG1P1		 0.457109	 0.0372241	 0.998676	
GLTSCR1L		 -0.45705	 0.0372519	 0.998676	
GAGE12G		 0.456877	 0.0373329	 0.998676	
ZNF583		 0.456833	 0.0373538	 0.998676	
SMARCD1		 0.456748	 0.0373933	 0.998676	
GAGE12G		 0.456659	 0.0374354	 0.998676	
BBS4		 0.456166	 0.0376677	 0.998676	
C7orf60		 -0.456061	 0.0377174	 0.998676	
TANC2		 0.455839	 0.0378226	 0.998676	
MIR597		 0.455748	 0.0378654	 0.998676	
IFNG		 0.455591	 0.0379403	 0.998676	
HERC6		 0.455547	 0.0379611	 0.998676	
EXT1		 -0.455381	 0.0380401	 0.998676	
OTTHUMG00000013217			 0.45523	 0.038112	 0.998676	
GOLGA6L2		 0.455064	 0.0381911	 0.998676	
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RNA5SP405		 -0.455031	 0.038207	 0.998676	
HNRNPH1		 -0.454911	 0.0382641	 0.998676	
SLIT3		 -0.454879	 0.0382797	 0.998676	
OTTHUMG00000017546			 0.454661	 0.0383838	 0.998676	
LOC100505613		 0.45451	 0.0384563	 0.998676	
RNA5SP431		 -0.454351	 0.038533	 0.998676	
OTTHUMG00000021064			 -0.454066	 0.0386699	 0.998676	
OTTHUMG00000021064			 -0.454066	 0.0386699	 0.998676	
PPP1R16B		 0.45405	 0.038678	 0.998676	
C19orf66		 0.45398	 0.0387118	 0.998676	
PPP1R12B		 0.453951	 0.0387255	 0.998676	
MIR3198-1		 -0.453894	 0.0387532	 0.998676	
FAM3C		 -0.453835	 0.0387818	 0.998676	
C9orf141		 0.453727	 0.0388339	 0.998676	
IGHJ1		 0.453674	 0.0388593	 0.998676	
ZNF561		 0.453583	 0.0389035	 0.998676	
LOC100129361		 -0.453549	 0.0389201	 0.998676	
HCAR2		 -0.453541	 0.0389238	 0.998676	
PVRL1		 0.453479	 0.0389539	 0.998676	
OTTHUMG00000152568			 -0.453148	 0.039115	 0.998676	
PCBD2		 0.452987	 0.0391931	 0.998676	
GPR75		 -0.452953	 0.0392099	 0.998676	
LINC00657		 -0.452595	 0.0393847	 0.998676	
CYB5D2		 0.45237	 0.0394946	 0.998676	
MFAP3		 0.45231	 0.0395243	 0.998676	
AXIN1		 0.45223	 0.0395635	 0.998676	
STARD10		 -0.452178	 0.0395892	 0.998676	
FKBP9		 -0.451846	 0.0397521	 0.998676	
C15orf41		 0.451799	 0.0397753	 0.998676	
CERCAM		 0.451432	 0.0399567	 0.998676	
ADM5		 0.451407	 0.0399689	 0.998676	
ALDOA		 -0.451401	 0.0399722	 0.998676	
LOC554174		 0.451056	 0.040143	 0.998676	
VAPA		 -0.450984	 0.0401787	 0.998676	
COPRS		 0.450972	 0.0401847	 0.998676	
LOC283731		 0.450685	 0.0403275	 0.998676	
SNORD101		 0.450556	 0.040392	 0.998676	
KPNA5		 -0.450388	 0.0404759	 0.998676	
LMAN2		 -0.450333	 0.0405032	 0.998676	
EXOSC9		 -0.45021	 0.040565	 0.998676	
C1orf74		 -0.450202	 0.0405686	 0.998676	
TYROBP		 -0.45018	 0.0405797	 0.998676	
KIAA1324		 -0.450097	 0.0406216	 0.998676	
SRSF10		 -0.449972	 0.0406839	 0.998676	
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TRAPPC10		 0.449757	 0.0407919	 0.998676	
DOM3Z		 0.449683	 0.0408293	 0.998676	
IL2RB		 0.449547	 0.0408976	 0.998676	
YTHDF1		 -0.449341	 0.0410017	 0.998676	
HINT3		 -0.449217	 0.0410642	 0.998676	
ZNF518A		 -0.449163	 0.0410915	 0.998676	
TAF9B		 -0.449114	 0.0411165	 0.998676	
EIF2B4		 0.448946	 0.0412011	 0.998676	
ATP6V0E2-AS1		 0.448659	 0.0413467	 0.998676	
AAGAB		 0.448647	 0.0413528	 0.998676	
KLHL6-AS1		 -0.448214	 0.0415733	 0.998676	
LRRC56		 0.448103	 0.0416301	 0.998676	
CCDC162P		 0.448059	 0.0416525	 0.998676	
OTTHUMG00000159297			 -0.448046	 0.0416592	 0.998676	
CHCHD1		 0.447365	 0.0420081	 0.998676	
MAP3K4		 0.447327	 0.0420279	 0.998676	
TALDO1		 -0.447244	 0.0420704	 0.998676	
RNA5SP113		 0.447081	 0.0421547	 0.998676	
OXGR1		 0.446357	 0.0425293	 0.998676	
ADCK4		 -0.446343	 0.0425366	 0.998676	
MN1		 0.446288	 0.0425652	 0.998676	
ASIC3		 -0.446219	 0.042601	 0.998676	
MAPK8		 -0.446117	 0.042654	 0.998676	
HSD17B11		 -0.445905	 0.0427643	 0.998676	
OTTHUMG00000179141			 0.445899	 0.0427674	 0.998676	
GOLIM4		 0.44586	 0.0427879	 0.998676	
SLC38A6		 -0.445817	 0.0428102	 0.998676	
SLC19A1		 -0.445721	 0.0428606	 0.998676	
RNA5SP354		 0.445547	 0.0429517	 0.998676	
KAT2A		 0.445514	 0.0429686	 0.998676	
TSPYL5		 0.445501	 0.0429755	 0.998676	
ORMDL3		 0.445397	 0.0430299	 0.998676	
LOC100128002		 0.445166	 0.0431514	 0.998676	
MOGAT3		 0.445137	 0.0431664	 0.998676	
HMGN2		 0.445003	 0.0432369	 0.998676	
HP07349		 0.444792	 0.0433481	 0.998676	
RPP21		 -0.444626	 0.0434353	 0.998676	
TRDV3		 0.44448	 0.0435124	 0.998676	
RNA5SP190		 -0.444473	 0.0435164	 0.998676	
SIDT2		 -0.444368	 0.0435722	 0.998676	
DHDDS		 -0.444234	 0.0436431	 0.998676	
OTTHUMG00000164913			 0.444137	 0.0436945	 0.998676	
TAF2		 -0.444081	 0.0437241	 0.998676	
CAPN3		 -0.443993	 0.0437708	 0.998676	
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OTTHUMG00000168876			 -0.443922	 0.0438083	 0.998676	
MIR4292		 0.443789	 0.0438789	 0.998676	
LOC100996455		 -0.443695	 0.0439294	 0.998676	
PPP3CB		 -0.443639	 0.0439592	 0.998676	
SETD3		 0.443586	 0.0439873	 0.998676	
ATAD3B		 -0.443555	 0.0440035	 0.998676	
OTTHUMG00000017366			 -0.443508	 0.0440289	 0.998676	
OTTHUMG00000161161			 0.443365	 0.0441052	 0.998676	
GAGE12J		 0.443299	 0.0441402	 0.998676	
NRSN2		 -0.44323	 0.0441774	 0.998676	
F8A1		 0.442843	 0.0443845	 0.998676	
NFYA		 -0.442683	 0.0444704	 0.998676	
DEGS2		 0.442674	 0.0444754	 0.998676	
CCDC13		 0.442564	 0.0445346	 0.998676	
PPAN-P2RY11		 0.442542	 0.0445463	 0.998676	
PAF1		 0.442482	 0.0445786	 0.998676	
NOXA1		 -0.442177	 0.0447431	 0.998676	
TP53I13		 0.441856	 0.044917	 0.998676	
MIR4686		 0.44174	 0.0449796	 0.998676	
NUP107		 -0.441731	 0.0449844	 0.998676	
MSRB3		 0.44166	 0.0450233	 0.998676	
MIR4492		 0.441558	 0.0450787	 0.998676	
KIAA0226		 0.441546	 0.0450848	 0.998676	
TAB2		 -0.44144	 0.0451425	 0.998676	
GPR56		 0.44141	 0.045159	 0.998676	
EFEMP2		 -0.441409	 0.0451595	 0.998676	
NFKBIE		 -0.441389	 0.0451705	 0.998676	
OTTHUMG00000067148			 0.44135	 0.0451919	 0.998676	
GIPC3		 -0.441264	 0.0452382	 0.998676	
TMEM218		 -0.441162	 0.0452939	 0.998676	
INGX		 0.44107	 0.0453445	 0.998676	
AGPAT2		 0.440997	 0.045384	 0.998676	
DHRS4L1		 -0.440994	 0.0453856	 0.998676	
CLCF1		 0.44094	 0.0454153	 0.998676	
C1QTNF9B-AS1		 0.440555	 0.045626	 0.998676	
MIR4316		 0.440555	 0.0456261	 0.998676	
RPS6KA2-IT1		 0.440465	 0.0456751	 0.998676	
TRBV25OR9-2		 -0.440395	 0.0457138	 0.998676	
SEC31B		 0.440248	 0.0457945	 0.998676	
CD300LF		 -0.44013	 0.0458596	 0.998676	
NKTR		 -0.440118	 0.0458663	 0.998676	
OAZ1		 -0.440112	 0.0458696	 0.998676	
PHF13		 0.440052	 0.0459023	 0.998676	
LOC254128		 -0.439943	 0.0459624	 0.998676	
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ZNF137P		 0.439804	 0.0460392	 0.998676	
TBXA2R		 -0.439713	 0.0460895	 0.998676	
C1orf50		 0.439469	 0.0462244	 0.998676	
CACNA1G		 0.439214	 0.0463661	 0.998676	
LETM2		 0.438867	 0.046559	 0.998676	
MIR518A2		 0.438677	 0.0466647	 0.998676	
NACAP1		 0.438668	 0.0466697	 0.998676	
LOC100128374		 -0.438609	 0.0467025	 0.998676	
CREM		 0.438579	 0.0467196	 0.998676	
ZNF250		 0.438431	 0.0468023	 0.998676	
CTBS		 -0.438377	 0.0468325	 0.998676	
AIF1		 -0.438275	 0.0468895	 0.998676	
AIF1		 -0.438275	 0.0468895	 0.998676	
AIF1		 -0.438275	 0.0468895	 0.998676	
AIF1		 -0.438275	 0.0468895	 0.998676	
EIF2S1		 -0.438179	 0.0469433	 0.998676	
ERN2		 0.437767	 0.0471747	 0.998676	
NAPB		 -0.437525	 0.0473107	 0.998676	
SLC22A8		 0.437522	 0.0473125	 0.998676	
LOC149086		 0.437479	 0.0473371	 0.998676	
NCKIPSD		 0.437445	 0.0473561	 0.998676	
OTTHUMG00000153714			 0.437398	 0.0473828	 0.998676	
LOC100133106		 0.437187	 0.0475019	 0.998676	
CCDC88B		 0.437173	 0.0475097	 0.998676	
PDIA3P		 -0.437146	 0.0475249	 0.998676	
TMEM128		 -0.43709	 0.0475567	 0.998676	
MIR644A		 -0.436946	 0.0476381	 0.998676	
ATP13A2		 0.436889	 0.0476706	 0.998676	
LAMTOR4		 -0.436725	 0.0477636	 0.998676	
OTTHUMG00000156122			 0.436724	 0.0477641	 0.998676	
RHOB		 0.436719	 0.0477674	 0.998676	
SCARNA10		 0.436604	 0.0478323	 0.998676	
RNA5SP134		 0.436603	 0.0478333	 0.998676	
LOC113230		 -0.4365	 0.0478915	 0.998676	
FUT10		 0.436396	 0.0479511	 0.998676	
VMA21		 0.436365	 0.0479684	 0.998676	
HMGA1P7		 0.436312	 0.0479989	 0.998676	
EOMES		 0.436293	 0.0480095	 0.998676	
OTTHUMG00000133664			 0.436171	 0.0480793	 0.998676	
NUDT21		 -0.436113	 0.0481122	 0.998676	
MFSD3		 0.436046	 0.0481509	 0.998676	
JKAMP		 -0.436045	 0.0481509	 0.998676	
PLD2		 0.435916	 0.0482249	 0.998676	
ZNF582		 0.435808	 0.0482868	 0.998676	
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MAGEC2		 0.43579	 0.0482974	 0.998676	
MGEA5		 -0.435766	 0.0483107	 0.998676	
BDH1		 0.435549	 0.0484354	 0.998676	
DLX6		 0.435492	 0.0484683	 0.998676	
PSMD5-AS1		 -0.435398	 0.0485224	 0.998676	
SH2B1		 0.435389	 0.0485274	 0.998676	
KLK9		 -0.435368	 0.0485396	 0.998676	
MRPL44		 -0.435	 0.0487514	 0.998676	
RAB1A		 -0.434864	 0.0488298	 0.998676	
SNORD99		 0.434642	 0.0489582	 0.998676	
C2orf57		 -0.434613	 0.0489749	 0.998676	
GALNS		 0.434597	 0.0489843	 0.998676	
OTTHUMG00000168002			 -0.434501	 0.0490401	 0.998676	
MXD1		 -0.434463	 0.0490619	 0.998676	
TEKT4P2		 -0.434431	 0.0490808	 0.998676	
ZNF514		 0.434389	 0.0491052	 0.998676	
ITGB2-AS1		 0.434129	 0.0492559	 0.998676	
H2AFB1		 0.434009	 0.0493259	 0.998676	
LY6H		 0.433966	 0.049351	 0.998676	
D2HGDH		 0.433728	 0.0494897	 0.998676	
MSH5		 0.433683	 0.0495162	 0.998676	
FGFBP2		 0.433134	 0.0498376	 0.998676	
SCARNA7		 0.432913	 0.0499675	 0.998676						
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